Back to Journals » OncoTargets and Therapy » Volume 11

A comparison of fulvestrant plus a targeted agent with fulvestrant alone in hormone receptor-positive advanced breast cancer that progressed on prior endocrine therapy: a meta-analysis

Total article views   HTML views PDF downloads Totals
7,612 Dovepress* 6,572+ 871 7,443
PubMed Central* 1,040 253 1,293
Totals 7,612 1,124 8,736
*Since 27 November 2018

View citations on PubMed Central and Google Scholar